NCT03125629View on ClinicalTrials.gov

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

May 27, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

February 5, 2020

Conditions
Cancer DiagnosisDiagnostic Techniques and ProceduresDiagnostic Imaging
Interventions
DRUG

F-18 FDG

Radiolabel for positron emission tomography / computed tomography (PET/CT) and computed tomography (PET/CT) imaging

DRUG

Ga-68-DOTA-TATE

Radiolabel for positron emission tomography / computed tomography (PET/CT) and computed tomography (PET/CT) imaging

DEVICE

Positron Emission Tomography / Computed Tomography (PET/CT) Scan

Scan using a regular medical care (IDE-exempt) Discovery 600 / 690 PET/CT scanner.

DEVICE

Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Scan

Scan using a NOVEL GE PET/MRI scanner.

Trial Locations (1)

94304

Stanford University, School of Medicine, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT03125629 - Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals | Biotech Hunter | Biotech Hunter